Trailing-twelve-month (TTM) revenue is $855.92 Million with a year-over-year growth of +0.07%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $217,960,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-05 |
| Q4 FY2025Period ended 2025-12-31 | $217,388,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-19 |
| Q1 FY2026Period ended 2026-03-31 | $209,691,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-05 |
| Q2 FY2026Period ended 2026-06-30 | $210,883,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-10 |
| TTM revenue | $855,922,000 |
Current P/S: $807,981,954 market capitalization ÷ $855,922,000 TTM revenue = 0.94x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T18:55:20.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $210.88M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T18:58:31.320Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Product | $383M | $501M | $648M | $740M | $809M | $831M |
| Service | N/A | N/A | N/A |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Non-US | $82M | $121M | $169M | N/A | $201M | $248M |
| North America | N/A | N/A | N/A |
$855.92M
$855.92 Million
+0.07%
vs. $855.32M a year ago (TTM)
+13.12%
5 Year compound annual growth rate
1 Year
+0.07%
3 Year
+5.26%
5 Year
+13.12%
10 Year
+20.45%
15 Year
N/A
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $859.79M | +$15.79M | +1.87% |
| 2024 | $844.01M | +$66.30M | +8.53% |
| 2023 | $777.71M | +$92.62M | +13.52% |
| 2022 | $685.08M | +$149.68M | +27.96% |
| 2021 | $535.40M | +$123.92M | +30.11% |
| 2020 |
TTM Growth
+0.07%
3-Year CAGR
+5.26%
5-Year CAGR
+13.12%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T18:58:31.320Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $35M |
| $28M |
| $643M |
| N/A |
| Other Country | N/A | N/A | N/A | $199M | N/A | N/A |
|---|
| UNITED STATES | $330M | $415M | $516M | $579M | N/A | $612M |
|---|
| $411.49M |
| +$84.54M |
| +25.86% |
| 2019 | $326.95M | +$82.86M | +33.94% |
| 2018 | $244.09M | +$43.15M | +21.47% |
| 2017 | $200.94M | +$43.50M | +27.63% |
| 2016 | $157.44M | +$46.91M | +42.44% |
